Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Sep;18(9):1320-6.
doi: 10.1023/a:1013046229699.

Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits

Affiliations

Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits

K Yokogawa et al. Pharm Res. 2001 Sep.

Abstract

Purpose: We investigated the effect of meropenem (MEPM) on the disposition kinetics of valproate (VPA) and its metabolites in rabbits.

Methods: Rabbits were given 75 mg/kg VPA intravenously with or without 300 mg/kg MEPM.

Results: The plamsa total clearance of VPA was significantly increased to about 1.5 times the control (6.09 mL/min/kg vs. 4.28 mL/min/kg) by MEPM (P < 0.05). The values of the area under the plasma concentration-time curve (AUC) of 2-en-VPA, a product of beta-oxidation, and VPA-glucuronide (VPA-G) were significantly decreased to about 55% and 78% of the control, respectively (P < 0.05). The cumulative urinary excretions of VPA in the control and MEPM-treated groups were 0.54% and 0.62% of the dose, respectively, whereas those of VPA-G were 45.6% and 62.5%, respectively. The urinary excretion of VPA-G was significantly increased by MEPM (P < 0.05). Further, in the case of 33.8 mg/kg VPA-G administered intravenously the AUC value of VPA-G was unchanged by MEPM, whereas that of the generated VPA was significantly decreased to about half of the control.

Conclusions: The increase of the total clearance of VPA caused by MEPM appears to be a consequence of increased renal clearance of VPA-G, as well as suppression of VPA-G hydrolysis in the liver.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Drug Metab Dispos. 1999 Jun;27(6):724-30 - PubMed
    1. J Antimicrob Chemother. 1998 Oct;42(4):563-4 - PubMed
    1. J Chromatogr B Biomed Appl. 1994 Jun 17;656(2):343-51 - PubMed
    1. Biochem Pharmacol. 1992 Feb 18;43(4):745-55 - PubMed
    1. Clin Pharmacokinet. 1996 Dec;31(6):470-93 - PubMed

LinkOut - more resources